These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 36381221)

  • 1. State-of-the-art management of dysplastic Barrett's esophagus.
    Vantanasiri K; Iyer PG
    Gastroenterol Rep (Oxf); 2022; 10():goac068. PubMed ID: 36381221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic therapy for Barrett's esophagus and early esophageal cancer: Where do we go from here?
    Singh T; Sanaka MR; Thota PN
    World J Gastrointest Endosc; 2018 Sep; 10(9):165-174. PubMed ID: 30283599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.
    Sawas T; Alsawas M; Bazerbachi F; Iyer PG; Wang KK; Murad MH; Katzka DA
    Gastrointest Endosc; 2019 May; 89(5):913-925.e6. PubMed ID: 30529044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
    Wani S; Rubenstein JH; Vieth M; Bergman J
    Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Radiofrequency Ablation for Dysplastic Barrett's Esophagus: A Comprehensive Review.
    Luigiano C; Iabichino G; Eusebi LH; Arena M; Consolo P; Morace C; Opocher E; Mangiavillano B
    Gastroenterol Res Pract; 2016; 2016():4249510. PubMed ID: 28070182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of Recurrent Intestinal Metaplasia and Dysplasia After Successful Endoscopic Therapy of Barrett's Neoplasia by Endoscopic Mucosal Resection vs Endoscopic Submucosal Dissection and Ablation: A Large North American Multicenter Cohort.
    Vantanasiri K; Joseph A; Sachdeva K; Goyal R; Garg N; Adoor D; Kamboj AK; Codipilly DC; Leggett C; Wang KK; Harmsen W; Hayat U; Chak A; Bhatt A; Iyer PG
    Am J Gastroenterol; 2024 Sep; 119(9):1831-1840. PubMed ID: 38587280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
    Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
    Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Today's Mistakes and Tomorrow's Wisdom in Endoscopic Treatment and Follow-Up of Barrett's Esophagus.
    Barret M
    Visc Med; 2022 Jun; 38(3):189-195. PubMed ID: 35814978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett's Esophagus and Related Neoplasia.
    Rubenstein JH; Sawas T; Wani S; Eluri S; Singh S; Chandar AK; Perumpail RB; Inadomi JM; Thrift AP; Piscoya A; Sultan S; Singh S; Katzka D; Davitkov P
    Gastroenterology; 2024 Jun; 166(6):1020-1055. PubMed ID: 38763697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
    Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
    Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of the mucosal ablation of Barrett's esophagus: efficacy and recurrence.
    Saligram S; Tofteland N; Wani S; Gupta N; Mathur S; Vennalaganti P; Kanakadandi V; Giacchino M; Higbee A; Lim D; Rastogi A; Bansal A; Sharma P
    Endosc Int Open; 2015 Jun; 3(3):E189-94. PubMed ID: 26171429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic therapy of esophageal premalignancy and early malignancy.
    Nealis TB; Washington K; Keswani RN
    J Natl Compr Canc Netw; 2011 Aug; 9(8):890-9. PubMed ID: 21900219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic eradication therapy for Barrett's oesophagus: state of the art.
    Kolb JM; Wani S
    Curr Opin Gastroenterol; 2020 Jul; 36(4):351-358. PubMed ID: 32487852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resection of early esophageal neoplasms: The pendulum swings from surgical to endoscopic management.
    Sanghi V; Amin H; Sanaka MR; Thota PN
    World J Gastrointest Endosc; 2019 Oct; 11(10):491-503. PubMed ID: 31798770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Barrett's esophagus with dysplasia refractory to radiofrequency ablation.
    Raphael KL; Trindade AJ
    World J Gastroenterol; 2020 May; 26(17):2030-2039. PubMed ID: 32536772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications, contraindications and limitations of endoscopic therapy for Barrett's esophagus and early esophageal adenocarcinoma.
    Rouphael C; Anil Kumar M; Sanaka MR; Thota PN
    Therap Adv Gastroenterol; 2020; 13():1756284820924209. PubMed ID: 32523628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on endoscopic treatment of Barrett's oesophagus and Barrett's oesophagus-related neoplasia.
    Pech O; Alqahtani SA
    Ther Adv Gastrointest Endosc; 2020; 13():2631774520935241. PubMed ID: 32783025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Location and appearance of dysplastic Barrett's esophagus recurrence after endoscopic eradication therapy: no additional yield from random biopsy sampling neosquamous mucosa.
    He T; Sundararajan V; Clark NJ; Slavin J; Tsoi EH; Thompson AJ; Holt BA; Desmond PV; Taylor ACF
    Gastrointest Endosc; 2023 Nov; 98(5):722-732. PubMed ID: 37301519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium.
    Gupta M; Iyer PG; Lutzke L; Gorospe EC; Abrams JA; Falk GW; Ginsberg GG; Rustgi AK; Lightdale CJ; Wang TC; Fudman DI; Poneros JM; Wang KK
    Gastroenterology; 2013 Jul; 145(1):79-86.e1. PubMed ID: 23499759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Outcomes of Cap Assisted Endoscopic Resection and Endoscopic Submucosal Dissection in Dysplastic Barrett's Esophagus.
    Codipilly DC; Dhaliwal L; Oberoi M; Gandhi P; Johnson ML; Lansing RM; Harmsen WS; Wang KK; Iyer PG
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):65-73.e1. PubMed ID: 33220523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.